Qualisure News

IN THE NEWS
PRESS REALEASES
EVENTS AND CONFERENCES

Notable Early Successes in Precision Oncology: The Breakthroughs That Redefined Cancer Treatment

Read More >
  • Open Access Govt
Bathe, O. F., Stretch, C.

Prognostic Biomarkers for Papillary Thyroid Cancer: Reducing Overtreatment, Improving Clinical Efficiency, and Enhancing Patient Experience

Read More >
  • Open Access Govt
Bathe, O. F.

Rethinking papillary thyroid cancer: Why “low risk” isn’t always low impact

Read More >
  • Open Access Govt
Bathe, O. F.

Cancer care through molecular diagnostics: Addressing papillary thyroid cancer

Read More >

Thyroid GuidePx® is now cited in the 2025 ATA Guidelines.

Read More >
  • Surgery
Craig, S., Stretch, C., Yeo, C., Fan, J., Pedersen, H., Joo Park, Y., Harvey, A., Bathe, O. F.

Prognostication With Thyroid GuidePX® in the Context of Tall Cell Variants

Read More >
  • ATA Annual Meeting
Fan, J., Bathe, O. F., Stretch, C.

ABSTRACT: RAI GuidePX: A Robust Predictor for Radioactive Iodine Sensitivity Status in Papillary Thyroid Cancer Leveraging Thyroid Differentiation Genes.

Read More >
  • ATA Annual Meeting
Allapitan, E., Fan, J., et al.

ABSTRACT: Molecular Subtypes in Radiation-Induced Papillary Thyroid Cancer Using Thyroid GuidePX®

Read More >

The Technological Drivers Powering Precision Oncology

Read More >

Unique Thyroid Cancer Tests: New Hope Unveiled

Read More >